ArticleFrontiers in oncology2025
Predictive model of malignancy probability in pulmonary nodules based on multicenter data.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pulmonary nodules: classification, biomarkers, signaling pathways, diseases, early diagnosis and management.Signal transduction and targeted therapy · 2026Review
- Benign vs. malignant pulmonary nodules: pleural adhesion risks and predictors.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- A Comprehensive Review of Radiomics in Pulmonary Nodule Management: Clinical Applications and Standardization Dilemmas.Current medical imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To study the characteristic factors associated with the occurrence of malignant nodules in patients presenting with pulmonary nodules, develop a predictive model, and evaluate its diagnostic performance. Methods: This study analyzed the clinical and imaging data of 830 patients with pulmonary nodules from the Affiliated Hospital of North Sichuan Medical College. The Least Absolute Shrinkage and Selection Operator (LASSO) and multivariate logistic regression analysis were utilized to identify characteristic predictors. Multiple machine learning classification models were employed for analysis, with the optimal model ultimately selected. A Shapley Additive Explanations (SHAP) framework was developed for personalized risk assessment. Finally, external testing was performed using data from 330 pulmonary nodule patients at Guang'an People's Hospital. Results: The predictive factors for malignant pulmonary nodules included: age, gender, nodule diameter, spiculation, lobulation, calcification, vacuole, vascular convergence sign, air bronchogram sign, pleural traction, and density of the nodule. The Gradient Boosting Decision Tree (GBDT) classification model demonstrated optimal performance, with an area under the curve (AUC) of 0.873 (95% confidence interval [CI]: 0.840-0.906) on the internal test set and 0.726 (95% CI: 0.668-0.784) on the external test set. Both the calibration curve and clinical decision curve analysis (DCA) indicated excellent model calibration and substantial clinical benefits. Conclusions: We developed a GBDT model that provides a basis for differentiating malignant pulmonary nodules, which may assist in the diagnosis and treatment of patients with pulmonary nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.